| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/11/2005 | DE102004003791A1 Verwendung von Phthalocyaninen als Markierungsstoffe für Flüssigkeiten The use of phthalocyanines as markers for liquids |
| 08/11/2005 | DE102004002289A1 Gasmessgerät mit einem elektrochemischen Sensor Gas meter with an electrochemical sensor |
| 08/11/2005 | DE102004002272A1 Moisture meter for soil testing is purely mechanical and operates by flexing of axial compound element constructed of two materials which respond differentially to dampness |
| 08/11/2005 | DE10163760B4 Vorrichtung und Verfahren zum Messen des Zustandes von Ölen und Fetten Apparatus and method for measuring the state of oils and fats |
| 08/11/2005 | DE10153925B4 Testgerät zum Nachweis von pharmakologisch wirksamen Verbindungen aus Speichel Test device for the detection of pharmacologically active compounds from the saliva |
| 08/11/2005 | CA2580478A1 Man2as as modifiers of the igfr pathway and methods of use |
| 08/11/2005 | CA2555381A1 Itpks as modifiers of the igfr pathway and methods of use |
| 08/11/2005 | CA2554846A1 Method of quickly measuring factor causing early flocculation of yeast |
| 08/11/2005 | CA2554825A1 Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone |
| 08/11/2005 | CA2554623A1 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of colon cancer |
| 08/11/2005 | CA2554599A1 Novel brain natriuretic peptide variants and methods of use thereof |
| 08/11/2005 | CA2554440A1 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer |
| 08/11/2005 | CA2554410A1 Biotherapeutics, diagnostics and research reagents |
| 08/11/2005 | CA2554403A1 Gastrointestinal proliferative factor and uses thereof |
| 08/11/2005 | CA2554286A1 Cjd prion testing |
| 08/11/2005 | CA2554266A1 Luminogenic and nonluminogenic multiplex assay |
| 08/11/2005 | CA2554216A1 Methods and compositons for treating cancer |
| 08/11/2005 | CA2554007A1 Diagnostic radio frequency identification sensors and applications thereof |
| 08/11/2005 | CA2553087A1 Detection of periodontal disease by detecting co-existence of bacterial and human substances in an oral cavity |
| 08/11/2005 | CA2552752A1 A handheld device with a disposable element for chemical analysis of multiple analytes |
| 08/11/2005 | CA2543635A1 System and methods for screening a luminal organ "lumen viewer" |
| 08/10/2005 | EP1562129A1 Method and apparatus for generating biologically-active-substance candidate structure |
| 08/10/2005 | EP1562047A1 Reagent kit for detecting lupus anticoagulant |
| 08/10/2005 | EP1562046A1 Method of diagnosing sepsis by detecting selectively the concentration of superoxide dismutase 1 (SOD-1) in samples |
| 08/10/2005 | EP1562045A2 Bioarray chip reaction apparatus and its manufacture |
| 08/10/2005 | EP1562044A1 Intracellular metabolic flux analysis method using substrate labeled with isotope |
| 08/10/2005 | EP1562039A1 Probe for physical properties measurement |
| 08/10/2005 | EP1561822A1 Detection of DNA damaging agents |
| 08/10/2005 | EP1561814A1 Gene expressed specifically in dopamine-producing neuron precursor cells after termination of division |
| 08/10/2005 | EP1561812A1 Modified sarcosine oxidase, process for producing the same and reagent composition using the same |
| 08/10/2005 | EP1561117A1 Diagnostic and therapeutic use of arl7 for alzheimer's disease |
| 08/10/2005 | EP1561116A2 Scd40l and placental growth factor (plgf) used as a biochemical marker combination in cardiovascular diseases |
| 08/10/2005 | EP1561115A1 Tel/etv6-mediated inhibition of cell proliferation |
| 08/10/2005 | EP1561114A1 Fret probes and methods for detecting interacting molecules |
| 08/10/2005 | EP1561113A1 A method for detecting, screening and/or monitoring a cancer in an individual |
| 08/10/2005 | EP1561112A1 Diagnosis of candidiasis and candidemia or invasive candida infection |
| 08/10/2005 | EP1561110A2 Assay products and procedures |
| 08/10/2005 | EP1561109A1 Analytical platform and detection method with analytes which are to be detected in a sample in the form of immobilized specific binding partners |
| 08/10/2005 | EP1561108A1 Nanoelectrode device for chemical analysis |
| 08/10/2005 | EP1561107A1 Method for identifying antigen specific b cells |
| 08/10/2005 | EP1561106A1 Diagnostic assay for measuring a cell mediated immune response |
| 08/10/2005 | EP1561105A2 Method for providing natural therapeutic agents with high therapeutic index |
| 08/10/2005 | EP1561104A1 Endothelial cells as diagnostic instrument in cardiovascular diseases |
| 08/10/2005 | EP1561103A1 Separating vessel |
| 08/10/2005 | EP1561100A1 Transistor-based biosensors having gate electrodes coated with receptor molecules |
| 08/10/2005 | EP1561099A1 Method of manufacture of electrochemical sensors |
| 08/10/2005 | EP1561097A1 Device and method for the recording of the surface characteristics of a fibrous structured long object |
| 08/10/2005 | EP1561094A1 Photometric determination of coagulation time in undiluted whole blood |
| 08/10/2005 | EP1560939A2 Immobilization of biological molecules onto surfaces coated with monolayers |
| 08/10/2005 | EP1560933A2 Methods and compositions for treating neurological disorders |
| 08/10/2005 | EP1560931A2 Functional and hyperfunctional sirna |
| 08/10/2005 | EP1560927A2 Diagnostic and therapeutic means for pathologies associated with alpha 2 subunit of the na, k pump |
| 08/10/2005 | EP1560925A2 Inhibitors of inflammatory gene activity and cholesterol biosynthesis |
| 08/10/2005 | EP1560915A2 Assay methods for state-dependent calcium channel agonists/antagonists |
| 08/10/2005 | EP1560850A2 Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion |
| 08/10/2005 | EP1560848A2 Ptprk immunogenic peptide |
| 08/10/2005 | EP1560847A2 Acetylated hmgb1 protein |
| 08/10/2005 | EP1560597A2 Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same |
| 08/10/2005 | EP1560593A1 Novel composition and methods for the treatment of immune related diseases |
| 08/10/2005 | EP1499895A4 Functionalized nanoparticles and methods of use |
| 08/10/2005 | EP1496928A4 Serum biomarkers in hepatocellular carcinoma |
| 08/10/2005 | EP1461616A4 Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample |
| 08/10/2005 | EP1461457A4 Single nucleotide polymorphisms and combinations thereof predictive for paclitaxel responsiveness |
| 08/10/2005 | EP1444356A4 Identifying and reducing the allergenicity of food proteins |
| 08/10/2005 | EP1409711A4 Compositions and methods for increasing amino acid absorption in mammals |
| 08/10/2005 | EP1404809A4 Improved skin substitutes and uses thereof |
| 08/10/2005 | EP1379682A4 Cell isolation method and uses thereof |
| 08/10/2005 | EP1336088B1 Step-wise process to recover or eliminate biological substances by flotation from underlayered colloidal medium |
| 08/10/2005 | EP1334360A4 Method for measuring nucleotides |
| 08/10/2005 | EP1314034A4 Methods for predicting impaired performance in equines |
| 08/10/2005 | EP1303751B1 Dyes and methods of detection of nucleic acid in immature red blood cells |
| 08/10/2005 | EP1301499A4 Stable isotope labeling of paclitaxel |
| 08/10/2005 | EP1290423B1 Biosensor and deposit sensor for monitoring biofilm and other deposits |
| 08/10/2005 | EP1133559B1 Human orphan g protein-coupled receptor rup3 |
| 08/10/2005 | EP1105737B1 Immunoassay for quantitative determination of the complex between prostate specific antigen (psa) and alpha2-macroglobulin (a2m) in a sample |
| 08/10/2005 | EP1079230B1 Method for screening substance promoting oligomerization of receptor protein molecules |
| 08/10/2005 | EP1051487B1 Placental protein 13 |
| 08/10/2005 | EP1002234A4 Sol-gel matrices for direct colorimetric detection of analytes |
| 08/10/2005 | EP0968288B1 A HUMAN 2-19 PROTEIN HOMOLOGUE, z219a |
| 08/10/2005 | EP0966685B1 Protein fragment complementation assays to detect biomolecular interactions |
| 08/10/2005 | EP0948639B1 Identification of blast cells in a leukocyte cell preparation |
| 08/10/2005 | EP0931094B1 Methods for determining the presence of brain protein s-100 beta |
| 08/10/2005 | EP0914344B8 ASSAY AND REAGENTS FOR QUANTIFYING hBNP |
| 08/10/2005 | EP0914150B1 Recombinant neospora antigens and their uses |
| 08/10/2005 | EP0894143B1 Vmp-like sequences of pathogenic borrelia |
| 08/10/2005 | EP0840125B1 Method for qantitatively determining an antibody having the ability to inhibit the activity of a reverse transcriptase |
| 08/10/2005 | EP0835452B1 Method and apparatus for pre-treating samples in an automatic chemical analyzer |
| 08/10/2005 | EP0794797B1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 08/10/2005 | CN2716841Y Fabric color-shifting tester |
| 08/10/2005 | CN2716840Y Water seepage coefficient determination instrument |
| 08/10/2005 | CN1653480A Optical projection imaging system and method for automatically detecting cells with molecular marker compartmentalization associated with malignancy and disease |
| 08/10/2005 | CN1653471A System for point of care diagnosis and/or analysis |
| 08/10/2005 | CN1653454A Method of forming molecule function network |
| 08/10/2005 | CN1653339A Device for analyzing a test sample and for providing corresponding analysis data |
| 08/10/2005 | CN1653337A Subunit vaccines with A2 supermotifs |
| 08/10/2005 | CN1653336A Diagnosis of hepatocellular carcinoma |
| 08/10/2005 | CN1653334A Biomolecular substrate, method of testing or diagnosis with use thereof and apparatus therefor |
| 08/10/2005 | CN1653333A Identifying peptide modifications |
| 08/10/2005 | CN1653331A Method for the determination of changes in a cellular morphological parameter |
| 08/10/2005 | CN1653330A Fluid tester |